HRP20020497B1 - Amycomycin, a process for its production and its use a pharmaceutical - Google Patents

Amycomycin, a process for its production and its use a pharmaceutical

Info

Publication number
HRP20020497B1
HRP20020497B1 HR20020497A HRP20020497A HRP20020497B1 HR P20020497 B1 HRP20020497 B1 HR P20020497B1 HR 20020497 A HR20020497 A HR 20020497A HR P20020497 A HRP20020497 A HR P20020497A HR P20020497 B1 HRP20020497 B1 HR P20020497B1
Authority
HR
Croatia
Prior art keywords
amycomycin
pharmaceutical
production
stereoisomeric
formulas
Prior art date
Application number
HR20020497A
Other languages
English (en)
Croatian (hr)
Inventor
Hopmann Cordula
Kurz Michael
Decker Heinrich
Le Beller Dominique
Aszodi Jozsef
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20020497A2 publication Critical patent/HRP20020497A2/hr
Publication of HRP20020497B1 publication Critical patent/HRP20020497B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
HR20020497A 1999-12-08 2002-06-06 Amycomycin, a process for its production and its use a pharmaceutical HRP20020497B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (2)

Publication Number Publication Date
HRP20020497A2 HRP20020497A2 (en) 2004-08-31
HRP20020497B1 true HRP20020497B1 (en) 2006-04-30

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020497A HRP20020497B1 (en) 1999-12-08 2002-06-06 Amycomycin, a process for its production and its use a pharmaceutical

Country Status (28)

Country Link
US (1) US6642391B2 (zh)
EP (2) EP1106604A1 (zh)
JP (1) JP4750993B2 (zh)
KR (1) KR100728514B1 (zh)
CN (1) CN1217929C (zh)
AT (1) ATE298744T1 (zh)
AU (1) AU781398B2 (zh)
BR (1) BR0016223A (zh)
CA (1) CA2393518C (zh)
CZ (1) CZ294370B6 (zh)
DE (1) DE60021109T2 (zh)
DK (1) DK1237866T3 (zh)
EE (1) EE05219B1 (zh)
ES (1) ES2243332T3 (zh)
HK (1) HK1048998A1 (zh)
HR (1) HRP20020497B1 (zh)
HU (1) HU225194B1 (zh)
IL (2) IL149904A0 (zh)
ME (1) ME00182B (zh)
NO (1) NO322565B1 (zh)
PL (1) PL201809B1 (zh)
PT (1) PT1237866E (zh)
RS (1) RS50288B (zh)
RU (1) RU2261916C2 (zh)
SI (1) SI1237866T1 (zh)
SK (1) SK286776B6 (zh)
WO (1) WO2001042210A1 (zh)
ZA (1) ZA200204420B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、mi710−51f6物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質mi481−42f4−a及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンbおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンaおよびbとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンcおよびdとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
RU2002118116A (ru) 2004-02-27
NO20022654L (no) 2002-06-05
US6642391B2 (en) 2003-11-04
JP2003516389A (ja) 2003-05-13
EE200200280A (et) 2003-06-16
PL355627A1 (en) 2004-05-04
SK7872002A3 (en) 2002-11-06
EE05219B1 (et) 2009-10-15
ZA200204420B (en) 2003-09-03
WO2001042210A1 (en) 2001-06-14
RS50288B (sr) 2009-09-08
IL149904A (en) 2007-10-31
DE60021109D1 (de) 2005-08-04
IL149904A0 (en) 2002-11-10
US20010018450A1 (en) 2001-08-30
MEP28508A (en) 2010-10-10
AU781398B2 (en) 2005-05-19
HUP0203593A3 (en) 2003-12-29
EP1237866A1 (en) 2002-09-11
SK286776B6 (sk) 2009-05-07
CA2393518C (en) 2009-01-20
KR20020063205A (ko) 2002-08-01
EP1237866B1 (en) 2005-06-29
DK1237866T3 (da) 2005-10-10
ATE298744T1 (de) 2005-07-15
AU2001901A (en) 2001-06-18
CZ20021891A3 (cs) 2002-08-14
ES2243332T3 (es) 2005-12-01
PT1237866E (pt) 2005-10-31
EP1106604A1 (en) 2001-06-13
YU13102A (sh) 2005-06-10
JP4750993B2 (ja) 2011-08-17
BR0016223A (pt) 2002-09-10
DE60021109T2 (de) 2006-05-04
RU2261916C2 (ru) 2005-10-10
PL201809B1 (pl) 2009-05-29
SI1237866T1 (en) 2005-10-31
CA2393518A1 (en) 2001-06-14
NO20022654D0 (no) 2002-06-05
CZ294370B6 (cs) 2004-12-15
HUP0203593A2 (hu) 2003-02-28
HK1048998A1 (en) 2003-04-25
HRP20020497A2 (en) 2004-08-31
CN1217929C (zh) 2005-09-07
NO322565B1 (no) 2006-10-23
KR100728514B1 (ko) 2007-06-15
HU225194B1 (en) 2006-08-28
CN1377341A (zh) 2002-10-30
ME00182B (me) 2010-10-10

Similar Documents

Publication Publication Date Title
RS50218B (sr) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje leka
HRP20030219B1 (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
HK1044945A1 (en) 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use.
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
NO2013017I1 (no) (a)dekstrometorfan eller et farmasøytisk akseptabelt salt, en forløper eller derivat, for eksempel ekstrometorfanhydrobromid og spesielt dekstrometorfanhydrobromid monohydrat; og (b) quinidin eller etfarmasøytisk akseptabelt salt, en forløper eller derivat derav, for eksempel quinidin og spesielt quinidinsulfat dihydrat
HRP20020306B1 (en) 6-position substituted indole, production and use thereof as a medicament
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
HUP0203190A3 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
PL354533A1 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
DE3874358D1 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AU7904600A (en) Substituted piperazine derivatives, the production and use thereof as medicaments
AU2011501A (en) Benzimidazoles, production thereof and the use thereof as antithrombotic
HRP20020497B1 (en) Amycomycin, a process for its production and its use a pharmaceutical
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
IL145041A (en) Morpholine derivatives, methods for the production thereof and pharmaceutical preparations
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
IT1317841B1 (it) Derivati del 3,9-diazabiciclo(3.3.1)nonano ad attivita' analgesica.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20160928

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20171125